FiercePharmaAsia—NextCODE’s $240M financing, Celltrion’s Inflectra plant, Biocon’s insulin plant

15th September 2017 Uncategorised 0

WuXi NextCODE has raised $240 million in a series B to build its genomics business, FDA slapped Pfizer’s partner Celltrion with a 12-observation Form 483, Biocon’s $275 million insulin plant in Malaysia opened shop and more.

More: FiercePharmaAsia—NextCODE’s 0M financing, Celltrion’s Inflectra plant, Biocon’s insulin plant
Source: fierce